(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors
for Advanced Gastrointestinal Stromal Tumors
36 locations incl. Birmingham
Sponsor: Cogent Biosciences, Inc.
Sex: All·Age: 18+
Code: NCT05208047·Phase 3·Recruiting